Concepedia

Sofie Martens

SM

Statistics

Publications

6

Citations

411

H-Index

6

Active since

2017

Affiliations

Ghent University(Current)

VIB-UGent Center for Inflammation Research

University of Antwerp

VIB-UGent Center for Medical Biotechnology

Frankfurt Cancer Institute

Sofie Martens is an author at Ghent University specializing in medicine, necroptotic signaling, and programmed necrosis.

Publications per year

2017–2022

6

Publications

6

Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death

Sandy Adjemian, Teodora Oltean, Sofie Martens et al. · Cell Death and Disease · 2020 · 154 citations · Full text

Medicine, Immunology, Immunotoxicology +16

Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury

Sofie Martens, Manhyung Jeong, Wulf Tonnus et al. · Cell Death and Disease · 2017 · 87 citations · Full text

Life Sciences, Oncology, Pharmacology +16

RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)

Sofie Martens, Vera Goossens, Lars Devisscher et al. · Cell Death and Disease · 2018 · 62 citations · Full text

Medicine, Medicinal Chemistry, Oncology +14

Tozasertib Analogues as Inhibitors of Necroptotic Cell Death

Sam Hofmans, Lars Devisscher, Sofie Martens et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells

Friederike Feldmann, Barbara Schenk, Sofie Martens et al. · Oncotarget · 2017 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 6